The current TRVI market cap is 220.31M. The company's latest EPS is USD -0.4565 and P/E is -7.54.
Quarter End | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 |
---|---|---|---|---|---|
USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
Total Revenue | 0 | 0 | 0 | 0 | 0 |
Operating Income | -8.41M | -6.66M | -7.56M | -8.38M | -9.05M |
Net Income | -8.27M | -5.51M | -6.4M | -7.15M | -7.7M |
Year End December 30 2022 | 2018 | 2019 | 2020 | 2021 | 2022 |
---|---|---|---|---|---|
USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
Total Revenue | 0 | 0 | 0 | 0 | 0 |
Operating Income | -18.41M | -26.65M | -32.49M | -32.48M | -29.91M |
Net Income | -25.58M | -25.22M | -32.76M | -33.94M | -29.15M |
Quarter End | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 |
---|---|---|---|---|---|
USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
Total Assets | 128.36M | 123.02M | 116.21M | 100.98M | 95.9M |
Total Liabilities | 18.46M | 15.56M | 14.47M | 5.9M | 6.29M |
Total Equity | 109.9M | 107.46M | 101.73M | 95.07M | 89.61M |
Year End December 30 2022 | 2018 | 2019 | 2020 | 2021 | 2022 |
---|---|---|---|---|---|
USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
Total Assets | 10.53M | 60M | 47.13M | 38.48M | 123.02M |
Total Liabilities | 4.28M | 5.46M | 19.85M | 21.4M | 15.56M |
Total Equity | -109.49M | 54.55M | 27.28M | 17.08M | 107.46M |
Quarter End | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 |
---|---|---|---|---|---|
USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
Operating | -21.84M | -28.18M | -8.2M | -18.07M | -25.35M |
Investing | -59.07M | -107.37M | 8.96M | 28.6M | 46.58M |
Financing | 110.66M | 111.31M | -1.7M | -9.37M | -7.86M |
Year End December 30 2022 | 2018 | 2019 | 2020 | 2021 | 2022 |
---|---|---|---|---|---|
USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
Operating | -18.29M | -23.09M | -29M | -28.95M | -28.18M |
Investing | -158k | -9k | -32k | N/A | -107.37M |
Financing | 3.63M | 73.21M | 16.72M | 20.78M | 111.31M |
Market Cap | 220.31M |
Price to Earnings Ratio | -7.54 |
Price to Sales Ratio | 0 |
Price to Cash Ratio | 17.45 |
Price to Book Ratio | 2.04 |
Dividend Yield | - |
Shares Outstanding | 63.86M |
Average Volume (1 week) | 249.95k |
Average Volume (1 Month) | 300.56k |
52 Week Change | 90.61% |
52 Week High | 4.00 |
52 Week Low | 0.97 |
Spread (Intraday) | 0.58 (15.98%) |
Company Name | Trevi Therapeutics Inc |
Address |
1209 orange street wilmington, delaware 19801 |
Website | https://www.trevitherapeutics.com |
Industry | pharmaceutical preparations (2834) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.